Replies to post #105459 on Biotech Values

[biomaven0]

MNTA’s take is roughly 10% of sales, not 10% of profits.

My mistake. So maybe of the order $150m/yr as IJ calculates instead, or perhaps higher depending on their margins. Still very substantial for a single generic product.

Peter